↓ Skip to main content

Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?

Overview of attention for article published in Frontiers in Psychiatry, December 2020
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?
Published in
Frontiers in Psychiatry, December 2020
DOI 10.3389/fpsyt.2020.598150
Pubmed ID
Authors

Benedikt Bernd Claus, Michael Specka, Heath McAnally, Norbert Scherbaum, Fabrizio Schifano, Udo Bonnet

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 16%
Researcher 3 16%
Student > Ph. D. Student 2 11%
Other 2 11%
Student > Bachelor 1 5%
Other 1 5%
Unknown 7 37%
Readers by discipline Count As %
Medicine and Dentistry 5 26%
Psychology 2 11%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Biochemistry, Genetics and Molecular Biology 1 5%
Business, Management and Accounting 1 5%
Other 2 11%
Unknown 7 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 January 2021.
All research outputs
#18,836,571
of 23,342,092 outputs
Outputs from Frontiers in Psychiatry
#7,166
of 10,456 outputs
Outputs of similar age
#379,550
of 509,453 outputs
Outputs of similar age from Frontiers in Psychiatry
#375
of 501 outputs
Altmetric has tracked 23,342,092 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 10,456 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 509,453 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 501 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.